MaSTherCell: Catalent to Acquire MaSTherCell Global for $315 Million

Somerset-based Catalent, Inc., a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc., for an aggregate of $315 million in cash, subject to a customary adjustments. "MaSTherCell extends [...]The post Catalent to Acquire MaSTherCell Global for $315 Million appeared first on New Jersey Business Magazine.